Literature DB >> 25754023

Use of implanted gold fiducial markers with MV-CBCT image-guided IMRT for pancreatic tumours.

Matthew Packard1, Olivier Gayou2, Krishna Gurram3, Brandon Weiss2, Shyam Thakkar3, Alexander Kirichenko2.   

Abstract

INTRODUCTION: Visualisation of soft tissues such as pancreatic tumours by mega-voltage cone beam CT (MV-CBCT) is frequently difficult and daily localisation is often based on more easily seen adjacent bony anatomy. Fiducial markers implanted into pancreatic tumours serve as surrogates for tumour position and may more accurately represent absolute tumour position. Differences in daily shifts based on alignment to implanted fiducial markers vs. alignment to adjacent bony anatomy were compared.
METHODS: Gold fiducial markers were placed into the pancreatic tumour under endoscopic ultrasound (EUS) guidance in 12 patients. Patients subsequently received image-guided intensity-modulated radiation therapy (IG-IMRT). MV-CBCT was performed prior to each fraction and isocentre shifts were performed based on alignment to the fiducial markers. We retrospectively reviewed archived MV-CBCT datasets and calculated shift differences in the left-right (LR), superior-inferior (SI) and anterior-posterior (AP) axes relative to shifts based on alignment to adjacent bony anatomy.
RESULTS: Two hundred forty-three fractions were analysed. The mean absolute difference in isocentre shifts between the fiducial markers and those aligned to bony anatomy was 3.4 mm (range 0-13 mm), 6.3 mm (range 0-21 mm) and 2.6 mm (range 0-12 mm), in LR, SI and AP directions, respectively. The mean three-dimensional vector shift difference between markers vs. bony anatomy alignment was 8.6 mm.
CONCLUSIONS: These data suggest that fiducial markers used in conjunction with MV-CBCT improve the accuracy of daily target delineation compared with localisation using adjacent bony anatomy and that gold fiducial markers using MV-CBCT alignment are a viable option for target localisation during IG-IMRT.
© 2015 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  IMRT; fiducial marker; image-guidance; pancreatic cancer; target motion

Mesh:

Substances:

Year:  2015        PMID: 25754023     DOI: 10.1111/1754-9485.12294

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  3 in total

1.  GRUPUGE Perspective: Endoscopic Ultrasound-Guided Fine-Needle Tattooing and Fiducial Placement in Pancreatic Cancer.

Authors:  Susana Marques; Miguel Bispo; Sílvia Leite; Teresa Moreira; Ana Caldeira; Pedro Moutinho-Ribeiro; Nuno Nunes
Journal:  GE Port J Gastroenterol       Date:  2020-07-28

2.  Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac.

Authors:  Yoko Goto; Ryo Ashida; Akira Nakamura; Satoshi Itasaka; Keiko Shibuya; Mami Akimoto; Nobutaka Mukumoto; Shigemi Matsumoto; Masashi Kanai; Hiroyoshi Isoda; Toshihiko Masui; Yuzo Kodama; Mitsuhiro Nakamura; Kyoichi Takaori; Takashi Mizowaki; Masahiro Hiraoka
Journal:  Oncotarget       Date:  2018-05-04

3.  EUS-guided placement of fiducial markers for image-guided radiotherapy in gastrointestinal tumors: A critical appraisal.

Authors:  Silvia Carrara; Mihai Rimbas; Alberto Larghi; Milena Di Leo; Tiziana Comito; Joseph Abi Jaoude; Cullen M Taniguchi; Christoph F Dietrich; Manoop S Bhutani; Stephan Hollerbach
Journal:  Endosc Ultrasound       Date:  2021 Nov-Dec       Impact factor: 5.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.